SBFM

SBFM

USD

Sunshine Biopharma Inc. Common Stock

$1.440-0.040 (-2.703%)

Echtzeitkurs

Healthcare
Drug Manufacturers - Specialty & Generic
Vereinigte Staaten

Kursdiagramm

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$1.480

Hoch

$1.510

Tief

$1.370

Volumen

0.02M

Unternehmensfundamentaldaten

Marktkapitalisierung

5.4M

Branche

Drug Manufacturers - Specialty & Generic

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

1.45M

Börse

NCM

Währung

USD

52-Wochen-Spanne

Tief $1.169Aktuell $1.440Hoch $23.2

Ähnliche Nachrichten

AccessWire

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic areas including oncology

Mehr anzeigen
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
AccessWire

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

Mehr anzeigen
Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering
AccessWire

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

FORT LAUDERDALE, FL / ACCESS Newswire / April 2, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

Mehr anzeigen
Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
AccessWire

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

FORT LAUDERDALE, FL / ACCESS Newswire / April 1, 2025 / Sunshine Biopharma Inc. , a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic

Mehr anzeigen
Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year